The Influence of Desensitizing Agent on Postoperative Sensitivity in Posterior Composite Restoration

Dentin Hypersensitivity Clinical Trial

Official title:

The Influence of Desensitizing Agent on Postoperative Sensitivity in Posterior Composite Restoration: A Randomized Controlled Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06113874
• Other study ID #: 7/22
• Status: Completed
• Phase: N/A
• Start date: July 5, 2022
• Est. completion date: August 30, 2023

Study information

• Verified date: October 2023
• Source: University of Alexandria
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aims to investigate the influence of desensitizing agents on reducing post-operative sensitivity in posterior composite.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 10
• Est. completion date: August 30, 2023
• Est. primary completion date: August 5, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• Patients having active primary class I carious lesions on vital molar teeth either in the middle or the inner third of dentin in the three quadrants of each patients.

• Teeth having a positive reaction to vitality test (cold test), no signs of pulp inflammation, or spontaneous pain before treatment.

• Preoperative radiographic record of the carious lesions.

• Buccolingual width is no more than half the inter-cuspal distance

Exclusion Criteria:

• Excessive tooth wear due to clenching or abnormal habits.

• Patients with direct occlusal contact by antagonist cusp (traumatic occlusion).

• Patients with periodontal or gingival disease.

• Patients using analgesics and/or anti-inflammatory medicine.

Related Conditions & MeSH terms

• Dentin Hypersensitivity
• Dentin Sensitivity
• Hypersensitivity

Intervention

Other:
• Hurriseal desensitizer
Patients will receive Hurriseal desensitizing agent and universal bond and composite. Cavities will be restored with light-cured composite resin following the application of bonding agent.
• Gluma desensitizer
Patients will receive Gluma desensitizing agent and universal bond and composite. Cavities will be restored with light-cured composite resin following the application of bonding agent.

Locations

Country	Name	City	State
Egypt	Faculty of Dentistry, Alexandria University	Alexandria

Sponsors (1)

Lead Sponsor	Collaborator
Nourhan M.Aly

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Hypersensitivity assessment	Air spray will be applied from a 2-mm distance on to the occlusal for 3 seconds. The severity of patients' pain/sensitivity will be recorded using (0-10) numerical rating scale. The score will be ranged from 0 (No pain) to 10 (maximum pain)	up to 12 months